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Evidence shows that fetuses and infants are more affected than adults by a variety of
environmental toxicants because of differential exposure, physiologic immaturity, and a longer
lifetime over which disease initiated in early life can develop. In this article we review data on the
effects of in uteroexposure to common environmental contaminants, including polycyclic aromatic
hydrocarbons (PAH), particulate matter and environmental tobacco smoke (ETS). We then
summarize results from our molecular epidemiologic study to assess risks from in uteroexposures
to ambient air pollution and ETS. This research study, conducted in Poland, used biomarkers to
measure the internal and bioeffective dose of toxicants and individual susceptibility factors. The
study included 160 mothers and 160 newborns. Ambient air pollution was significantly associated
(p < 0.05) with the amount of PAH bound to DNA (PAH-DNA adducts) in both maternal and infant
cord white blood cells (WBC). Newborns with elevated PAH-DNA adducts (greater than the
median) had significantly decreased birth weight (p = 0.05), birth length (p = 0.02), and head
circumference (p = 0.0005) compared to the newborns with lower adducts (n = 135). Maternal
and infant cotinine levels were increased by active and passive cigarette smoke exposure of the
mother (p < 0.01). An inverse correlation was seen between newborn plasma cotinine (nanograms
per milliliter) and birth weight (p = 0.0001) and length (p = 0.003). Adducts were elevated in
placental tissue and WBC of newborns who were heterozygous or homozygous for the
cytochrome P4501A1 MspI restriction fragment length polymorphism (RFLP) compared to
newborns without the RFLP. Levels of PAH-DNA and cotinine were higher in newborns than
mothers. These results document that there is significant transplacental transfer of PAH and ETS
constituents from mother to fetus; that PAH-DNA adduct levels in maternal and newborn WBC
were increased with environmental exposure to PAH from ambient pollution; and that the fetus is
more sensitive to genetic damage than the mother. The study also provided the first molecular
evidence that transplacental PAH exposure to the fetus is compromising fetal development. If
confirmed, these findings could have significant public health implications since a number of
studies have found that reduction of head circumference at birth correlates with lower intelligence
quotient as well as poorer cognitive functioning and school performance in childhood. Key words:
air pollution, cigarette smoking, CYP1A1 MspI RFLP, GSTM1, newborns, PAH-DNA adducts,
Poland. - Environ Health Perspect 107(suppl 3):451-460 (1999).
http://ehpnet1.niehs.nih.gov/docs/1999/suppl-3/451-460perera/abstracthtml
The context of the work reviewed here is
the growing awareness ofthe vulnerability
ofthe developing fetus and child to certain
environmental contaminants, including
those commonly found in urban areas
around the world. Following a summary of
the toxicity and occurrence ofpolycyclic
aromatic hydrocarbons (PAH), particulate
matter (PM), and, environmental tobacco
smoke (ETS), we discuss molecular epi-
demiology and biomarkers as research
tools. We then review the results of
research undertaken in Poland to assess
risks from in uteroexposures in newborns.
EnhancedSusceptibilityofthe
DevelopingFetusandInfant
Evidence indicates that fetuses and infants
are more affected than adults by a variety of
environmental toxicants because ofdifferen-
tial exposure, physiologic immaturity, and a
longer lifetime over which disease initiated
in early life can develop. Experimental and
human data indicate that the fetus and the
young child are especially vulnerable to
the toxic effects ofPAH, ETS, PM, nitro-
samines, pesticides, polychlorinated
biphenyls (PCBs), and metals (1-6).
Several studies suggest that the fetus
may be more prone to genetic damage and
clears toxicants less efficiently than the
adult. For example, given experimental evi-
dence that the amount of PAH crossing
the placenta and reaching the fetus is less
than one-tenth of the dose to the mother
(7,8), the levels of PAH-DNA adducts
measured in rodent fetal tissue were higher
than expected (9,10). As will be discussed,
the same pattern was seen in Polish new-
borns (11). Increased adducts in the fetus
relative to the adult could result from
lower levels of phase II (detoxification)
enzymes, decreased DNA repair efficiency
in the fetus, or to lower fetal body fat,
which sequesters some of the PAH in
adults (1,3,12). In addition, a previous
study reported higher levels ofcotinine (a
metabolite of nicotine) in fetal samples
than in paired maternal samples (13),
although others did not (14,15).
In particular, the developing nervous
system is an extremely sensitive target
(16,17). The central nervous system (CNS)
and the peripheral nervous system both
comprise highly specialized organs and tis-
sues that are vulnerable to deficits in oxygen
and nutrients and to damage by toxic
chemicals. During the prenatal period, the
developing fetal brain undergoes tremen-
dous growth and differentiation as cells
divide and migrate to form structures in
many areas simultaneously. Neurotoxicants
present in fetal circulation or tissues will
have ready access to these activated cells, as
the blood brain barrier does not develop
until after birth. Because many brain areas
are developing at the same time, prenatal
exposures to toxicants might be expected to
produce somewhat general effects on
growth and development. Neurotoxicants
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would also be expected to interfere with the
optimal development ofthe CNS structures
if they are present during growth spurts in
these structures. Examples ofrelatively well-
characterized neurotoxicants affecting the
fetus are lead, PCBs, and cocaine (18-20).
The evidence for ETS is more limited
(21). Circumstantial evidence regarding
neurotoxicity ofPAH is presented below.
Because brain development continues
after birth, postnatal exposures to toxi-
cants may be no less damaging than pre-
natal exposures but are likely to be more
specific. For example, the organization of
cortical, limbic, and cerebellar circuitry
occurs postnatally and is sensitive to toxi-
cant exposure. Also, the deposition of
myelin and the proliferation of granule
cells in the hippocampus are late develop-
mental events that may be compromised
by postnatal exposures. Susceptibility may
depend upon the timing of the exposure
with respect to the stages ofbrain develop-
ment, the duration of the exposure, and
the total amount ofthe exposure. Multiple
exposures during early life may lead to
cumulative neurobehavioral deficits.
The National Research Council and the
U.S. Environmental Protection Agency
have recognized the need for risk assess-
ment and public health policy to pay spe-
cial attention to protecting young infants
and children from environmental toxicants
(1,6,22). However, major gaps in knowl-
edge have impeded the development of
public health policy capable ofeffectively
protecting the developing fetus and child.
First, epidemiologic studies have been lim-
ited by the lack ofaccurate data on individ-
ual exposures and individual variation in
response to toxicants (23). Second, there
has been little effort to disentangle the
influences of multiple environmental and
susceptibility factors on growth and devel-
opment. Research is needed to generate
information on the magnitude ofindivid-
ual variation in exposure and susceptibility
within this young population, as well as on
the relationship between these factors and
developmental impairment.
Domains ofFetalGowthand
DevelopmentLikelyto BeAflfcted
byPAH, PM, andEIS Exposures
The most commonly measured parameters
of fetal growth and development in the
study ofprenatal exposure to toxicants are
head circumference, birth weight, birth
length, and, to a lesser extent, size for ges-
tational age (or growth retardation). Experi-
mental and molecular epidemiologic studies
have associated growth retardation with
transplacental exposure to ETS and PAH.
With respect to head circumference, most
head growth occurs during the prenatal
period, with more than 60% ofadult head
circumference attained at birth (24). The
evidence that head circumference may be
reduced by toxicant exposure comes largely
from the prenatal alcohol and cocaine
exposure literature. Some studies have
linked prenatal cocaine exposure to a 1-2
cm reduction in infant head circumference
(18-20). The literature suggests that
reduction in infant head circumference at
birth or during the first year of life is
correlated with lower intelligence quotient
(IQ) as well as poorer cognitive function-
ing and school performance in childhood
(20,25,26). As will be discussed, we have
found a significant association between ele-
vated PAH-DNA adducts and a 0.9 cm
decrement in head circumference of new-
borns (27). Others have shown that prena-
tal exposure to maternal tobacco smoke is
associated with effects on cognitive devel-
opment at age 3 years (28). Thus, the
effect of prenatal exposure to PAH and
ETS on cognitive development warrants
further investigation.
ToxicityandOccurrenceofPolycylic
Aromatic Hydrocbons
Polycyclic aromatic hydrocarbons are
among the best-characterized environmen-
tal toxicants. A number ofPAH are repro-
ductive and developmental toxicants, as
well as mutagens and carcinogens. In addi-
tion to their ability to bind to and damage
DNA, PAH such as benzo[a]pyrene
(B[a]P) are capable of disrupting the
endocrine system by altering metabolic
pathways of natural hormones or other-
wise interfering with their activity (29,30).
Laboratory studies have found an associa-
tion between transplacental exposure to
certain PAH and adverse reproductive out-
comes. Pregnant animals exposed to B[a]P
and other PAH showed an increase in
stillbirths, reabsorption and congenital
abnormalities, and decreases in fetal
weight (29,31-36). Subcutaneous admin-
istration ofB[a]P to pregnant rats caused
significant decreases in number oflive off-
spring and in fetal weight, and significant
increases in reabsorption sites (p < 0.05)
(29). In the same experiment, B[a]P
administration to pseudopregnant rats
resulted in significant decreases in uterine
weight. Similarly, gavage administration of
coal liquefaction products containing high
levels ofPAH to pregnant Sprague-Dawley
rats caused significant intrauterine growth
retardation and decreases in the number
of live pups (34). Some studies suggest
that effects oftransplacental B[a]P admin-
istration on fetal weight may persist into
the postnatal period. After oral adminis-
tration of B[a]P to pregnant CD-1 mice,
pup weight was significantly depressed at
day 20 and day 42 postnatal examination
(32). The B[a]P diol-epoxide (BPDE) is
a potent embryotoxin and teratogen,
causing 100% malformations in Swiss
mice pups following embryonal injection
of BPDE, compared to 21% malforma-
tion in controls receiving vehicle-only
injections (31).
There is evidence in humans that PAH,
fine particles, and other pollutants from
burning ofcoal may adversely affect birth
outcomes. There was an excess prevalence
oflow birth weight and premature births in
a polluted district of the Czech Republic
(Teplice) compared to Prachatice, where
pollution was low (37). These adverse
effects were more common in infants con-
ceived in the winter months and whose
mothers were smokers (21). As mentioned,
our research suggests that PAH in air pollu-
tion adversely affect birth weight, length,
and especially head circumference (27). A
possible mechanism for the latter is the
induction of apoptosis following DNA
damage by PAH.
PAH are widespread pollutants
commonly found in ambient air, as well as
workplace air, food, and drinking water
(38). Incomplete combustion ofgasoline
and diesel fuels by transportation sources,
and burning ofcoal and oil for industrial
purposes and residential heating are the
major sources ofambient PAH. ETS and
home cooking and heating are the most sig-
nificant indoor sources ofairborne PAH
(39-41) . The PAH with five or more rings
(e.g., B[a]P) occur predominantly in the
particulate phase, associated with deeply
respirable particles smaller than 2 pm in
diameter (42). Most studies that include
both winter and summer data have found
that PAH concentrations are higher during
the winter (43-45). In addition to its occur-
rence in ambient air, B[a]P is a constituent
of mainstream cigarette smoke (20-40
ng/cigarette) and sidestream smoke (68-136
ng/cigarette in undiluted smoke) (46).
Drinking water intake is a less important
source, generally less than 0.1 ng/L (47).
Diet can be an important source ofB[a]P
(47), which is present in a wide variety of
foods including charbroiled, grilled or
smoked meatand fish (48,49).
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ToxicityandOccuence
ofParticulateMatter
The effects of PM on the developing fetus
and infant have not been adequately
studied. A research project in the Czech
Republic found that during winter inver-
sions in the more polluted area ofTeplice,
fine particles were dominated by acidic sul-
fates, organic compounds, and toxic trace
elements-largely from the combustion of
coal. There was an excess prevalence oflow
birth weights, premature births, and neu-
robehavioral problems in Teplice, com-
pared to a less polluted area (21). A study
in Beijing found an association between
maternal exposure to total suspended par-
ticulate (TSP) and sulfur dioxide during
the third trimester and decreased birth-
weight (50). Also in Beijing, preterm deliv-
ery was associated with TSP and sulfur
dioxide (51). Finally, in the United States,
postneonatal infant mortality has been
associated with PM (52).
Combustion ofcoal, oil, gasoline, diesel
and wood are among the major sources of
respirable PM in urban air (53). However,
individual exposure depends on particles
encountered both indoors and outdoors,
with indoor exposures being ofprime con-
cern because the vast majority of time is
spent indoors. Infiltration ofambient res-
pirable particulates into interior spaces
occurs readily because ofthe low mass and
long atmospheric residence times oftiny
suspended particles (54,55). In homes with
no smokers, indoor levels are typically simi-
lar to those measured outdoors (56).
However, the contribution ofsmoking to
indoor PM2.5 (diameter <2.5 pm) concen-
trations can be substantial, depending on
numbers of cigarettes smoked. Other
important indoor sources include cooking
fumes, resuspended dust from carpets, fur-
niture, and clothes, and emissions from
stoves and kerosene heaters (57,58). PM2.5
mass concentrations represent a heteroge-
neous mix ofcompounds, including sul-
fates, nitrates, elemental carbon, organic
compounds including PAH, and metals
including lead, cadmium, nickel, copper,
vanadian, and zinc (53). In particular, there
is a growing concern about the health
effects of emissions from diesel exhaust.
Diesel vehicles emit 30-100 times more
particles than gasoline engines with con-
temporary emission-control devices (59).
The relatively small size of the diesel
exhaust particles (mass median diameter of
0.05-0.3 pm) makes them readily res-
pirable (60). The particulate fraction is
mainly formed ofelemental carbon particles
with organic compounds such as PAH and
othercarcinogens adsorbed on theirsurface.
ToxicityandOccuenceofETS
ETS is an important source of PAH and
appears to be an independent risk factor for
fetal and child growth impairment capable
of acting via non-PAH constituents. In
addition to PAH, tobacco smoke contains
carbon monoxide and a host ofother devel-
opmental toxicants. ETS is a cause oflow
birth weight (LBW) and deficits in birth
weight and height that persist into infancy
and childhood. Prenatal exposure to mater-
nal tobacco smoke has been shown to affect
fetal growth and cognitive functioning at
age 3 years (28,61). The effect ofprenatal
exposure to the mother's ETS on cognitive
development has not been adequately stud-
ied. Paternal smoking has been associated
with a reduction of 88 g in birth weight
(62). The effect ofpostnatal ETS exposure
is not clear (63); however, one study
reported that reduced height was associated
with postnatal parental smoking in the
home, regardless ofwhether the mother
smoked during pregnancy and regardless of
which parent smoked (64). The effect of
smoking on birth weight is thought to
result in part from a reduction in blood
supply to the fetus via vasoconstriction of
umbilical vessels and an increase in fetal
carboxyhemoglobin levels.
Several epidemiologic studies also indi-
cate that exposure to ETS in utero or in
childhood increases lifetime risk ofcancer
(46,65-67). An estimated 17% oflung
cancers among nonsmokers has been attrib-
uted to high levels ofETS exposure during
early childhood and adolescence (66).
Individual ETS exposure varies widely,
depending on the number of smokers,
amount smoked, amount of time spent
indoors with smokers, and ventilation char-
acteristics ofthe home. As discussed in the
following section, ETS exposure in Poland
is high (68,69). Similarly, ETS is a common
urban pollutant in the United States, as evi-
denced by a recent finding ofelevated coti-
nine levels in 80% of inner-city children
sampled (70).
Moleculamr Epdemiology
andBiomakr
Most of the research to date has lacked
adequate exposure and dosimetry data to
forge causal links between common envi-
ronmental factors and health effects in the
young. In this regard, molecular epidemi-
ology using biomarkers can be a valuable
tool in defining environment-susceptibility
relationships when used in conjunction
with sound monitoring and epidemiologic
methodologies (23,71-76). The following
biomarkers were used in our research in
Poland to assess the effects of in utero
exposure and genetic susceptibility:
Plasma cotinine. Cotinine is a useful
marker ofexposure to tobacco smoke, with
a half-life of 15-40 hr (77,78). A number
ofstudies have concluded that cotinine is
the most valid biologic indicator ofactive
or passive exposure over the previous sev-
eral days (79-81). A single determination
also gives a good impression ofsteady-state
levels in people having stable smoking
habits (79). Cotinine readily crosses the
placenta and is detectable in fetal samples
(15,82). Cotinine levels have been used as
an internal dosimeter in several studies of
nonsmoking pregnant women to evaluate
the effects ofETS exposure on fetal devel-
opment. We and others have seen a signifi-
cant association between ETS exposure
during pregnancy and cotinine levels in
maternal and infant samples collected at
delivery (83,84). Significant decrements in
birth weight in cotinine-determined ETS
exposed compared to nonexposed infants
were seen in some (85,86) but not all
studies (87).
PAH-DNA adduct levels in white
blood cells. Because DNA adducts are a
biomarker that reflects individual variation
in metabolism as well as repair of DNA
damage, they provide an informative indi-
vidual biologic dosimeter ofspecific geno-
toxic pollutants, supplementing monitoring
ofexternal exposures (88-90). With respect
to developmental effects, our observation of
a highly significant inverse correlation
between decreased head circumference at
birth and increased PAH-DNA binding
(27) is consistent with other evidence that
the developing CNS is particularly sensitive
to DNA-damaging agents (91-93) and
may respond by activating apoptotic path-
ways (27). Thus, although within a devel-
opment study, we consider adducts to be
primarily a dosimeter of environmental
PAH, they may also reflect a mechanism of
toxicity. In experimental studies, there is a
high correlation between DNA adduct
formation and carcinogenicity for a series of
mutagens/carcinogens, including B[a]P
(89,90,94). Supporting the use ofperiph-
eral blood cells as a surrogate for target tis-
sue, experimental and human studies
indicate comparable levels ofDNA adducts
across many tissues, including peripheral
blood (88,95).
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Cytochrome P4501A1 genotype and
induction. Genetic differences in detoxifi-
cation capabilities may modulate PAH-
induced carcinogenesis (96). CYPlA1 is
an inducible enzyme system that catalyzes
the biotransformation ofPAH to phenolic
products and epoxides (97,98). These can
be further biotransformed by epoxide
hydrolase and other enzymes to reactive
metabolites capable of binding to DNA
(99). A MspI restriction fragment length
polymorphism (RFLP) has been identified
in the 3' noncoding region ofthe CYPIAI
gene (the CYPIAJ MspI RFLP). It segre-
gates in linkage disequilibrium with a
polymorphism in exon 7 that results in an
lle -> Val substitution in the catalytic
region. Both CYPIAJ polymorphisms have
been associated with lung cancer risk in
some, but not all, studies (100-106).
CYPlAI is inducible in human placental
and other tissues. CYPlAl mRNA reflects
gene induction, whereas aryl hydrocarbon
hydroxylase (AHH) and 7-ethoxyresorufun
O-deethylase (EROD) are measures of
enzyme activity. In human lung, a signifi-
cant correlation has been seen between
AHH activity and carcinogen-DNA adduct
levels, including those formed by B[a]P, a
representative PAH (107,108). In human
placenta, induction ofAHH and EROD
activity as a result ofmaternal smoking has
been well documented (98,109-111). One
study found a high correlation between
AHH activity and the formation ofthe pro-
carcinogenic B[a]P-7,8-diol in human pla-
cental tissue (110); others did not see ahigh
correlation between measures ofCYPlAI
activity and BPDE-DNA adduct levels
(112,113). Evidence suggests that CYPlAI
activity in the placenta reduces transfer of
PAH to the fetus (114,115).
Glutathione S-transferase Ml.
Glutathione S-transferase Ml (GSTM1)
codes for an enzyme involved in the detoxi-
fication of PAH via conjugation of acti-
vated metabolites with glutathione. An
estimated 30-60% of populations are
deleted at this locus (116). The GSTM1
null genotype has been associated with
increased riskoflung cancer (88,117-119),
albeit not consistently (120-122). Previous
evaluations ofthe association between the
CYPIAJ and GSTM1 polymorphisms and
carcinogen-DNA adduct levels have
provided conflicting results (123-127).
Krakow, Poian&AUnique
OppornityforReser
The ethnically homogeneous population in
Krakow, Poland, provides a valuable model
for the evaluation of the health effects of
ambient and indoor air pollution (PAH,
PM, and ETS). The ambient air in the
industrialized city of Krakow contains
relatively high concentrations of PAH,
PM and other environmental pollutants
compared to other areas of the country,
with the exception of Silesia (128). The
pollution is attributable to transportation
sources, industrial sources, and coal-burning
furnaces, and is heaviest in the older, cen-
tral section ofthe city (129,130). During
the last 10 years, sulfur dioxide and PM
concentrations have decreased as a result of
the reduced productivity of the old heavy
industry within and around the city, and
the introduction ofa gas-operated heating
system in the city (covering approximately
30% ofthe homes). However, the levels of
PAH, PM, and heavy metals continue to
be high in the central city because of
increasing traffic (especially diesel) and
continued coal burning by industrial and
residential sources. Krakow also receives air
pollution from the Upper Silesia coal
region (130).
PAH are major toxic constituents ofair
pollution in Krakow. According to air
monitoring data provided by the Office of
Environmental Protection, which operates
monitoring stations in Krakow, in 1996,
annual average concentrations ofB[a]P, a
representative PAH, were 2-fold higher in
Srodmiescie, the most polluted, central
area of Krakow (annual average 13.3
ng/m3, 22.4 in winter; 4.6 in summer)
than in Krowodrza, the cleanest area
(annual mean of 6.0 ng/m3; 11.2 winter;
0.9 summer). There was an almost 5-fold
seasonal variation in PAH concentrations
within Srodmiescie and 12-fold variation
within Krododrza.
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Levels ofrespirable particulates are also
high in Krakow. During 1991, the year
prior to the birth of the infants in our
study, annual average levels ofrespirable
particulates (< 10 mm in diameter) were 78
pg/m3 in the high pollution area and 38
pg/m3 in the low-pollution area ofthe city.
As seen from Figure 1, particulate pollu-
tion has been reduced since 1991 but still
remains high and continues to vary by
approximately 2-fold between Srodmiescie
and Krowodrza. There is also significant
seasonal variability in particulate levels.
ETS exposure is high in Poland. A
1992 study ofnonsmoking Polish women
found that the vast majority were exposed
to ETS either at home or the workplace
and that urinary cotinine was detected in
92% of the nonsmoking women sampled
(68). In our study, 58% ofthe nonsmok-
ing women from Krakow reported ETS
exposures, and among these nonsmoking
women, cotinine was detected in 42% of
the blood samples collected from their
infants at birth (11).
Rates ofinfant mortality and LBW have
increased significantly in Poland between
1985 and 1995 and are higher in the
industrialized, heavily contaminated regions
of the country than in the rural areas
(131-133). Ambient air pollution has been
suggested as a possible causal agent
(128,134). The highestlevels ofinfant mor-
tality are generally found in the provinces
with the most severe ambient pollution
levels. Preliminary data suggest a correlation
between infant mortality rates and several
measures ofambient air pollution, including
dustfall and B[a]P (128). A 1990 study of
placentas from 1,000 nonsmoking mothers
in Krakow and other polluted areas in
Poland found a high prevalence ofgross
1991 1992 1993 1994 1995
Figure 1. Levels of respirable particulates 1991-1995 (winter/summer) in high-polluted (Srodmiescie) and low-
polluted (Krowodrza) areas ofthe Krakow.
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structural changes in placentas from central
Krakow that could have contributed to
growth impairment of the fetuses (128).
An ecologic analysis compared birth
weights and rates ofstillbirths for cities and
rural villages ofPoland from 1975 to 1988
(135). The incidence of LBW (< 2,500 g)
and stillbirths was higher in the cities com-
pared to the villages. The authors con-
cluded that this finding could not be
attributed to differences in diet or parental
stature, and that it was probably due to the
negative effects ofurbanization and indus-
trialization, including environmental pollu-
tion (135). A more recent case-control
study found that urban residency was also
a significant risk factor for small-for-
gestational-age infants, controlling for
other potential confounders (136).
In addition, there is evidence of "hot
spots" for cancer mortality that correspond
to geographical areas within Poland that are
characterized by heavy industrialization and
high pollution (137). Krakow has an excess
of lung cancer deaths compared with
Poland overall. Jedrychowski and colleagues
have reported a statistically significant asso-
ciation between air pollution in Krakow
and lung cancer risk among men (129).
A Molecular Epidemiologic
Study in Polish Newborns
and Mothers
MajorAims
* Evaluate the relationship between ambi-
ent exposures and PAH-DNA adducts.
* Assess the effect ofgenetic/metabolic
markers (placental CYPlAl mRNA and
EROD activity), GSTM1 genotype,
and CYPlAl MspI polymorphism on
adduct levels.
* Compare DNA adducts in maternal
and fetal/newborn samples to assess
possible differences in response and
susceptibility.
* Assess the association between infant
PAH-DNA adduct levels and birth
outcomes (birth weight, length, and
head circumference) after controlling
for gestational age.
StudyDesign
The study included 320 subjects: 70
mother/newborn pairs from Krakow and
90 mother/newborn pairs from Limanowa,
a small town in a rural agricultural district
of Poland with lower ambient pollution
but heavier use ofcoal for residential heat-
ing (27,138). Enrollment was restricted to
women who had resided in Krakow or
Limanowa for at least 1 year and was
limited to vaginal deliveries. Enrollment
alternated on a biweekly basis between
Krakow and Limanowa in the winter of
1992 to control for monthly variations in
pollutant levels. Immediately after delivery,
samples of umbilical cord blood and pla-
centa were collected. A maternal blood
sample was collected within 2 days post-
partum. Samples were processed and stored
as described (138).
A questionnaire administered to the
mother within 2 days postpartum included
information on smoking, residential and
employment histories, use ofcoal stoves for
residential heating, and other environmental
exposures. Subjects were asked to estimate
the average number ofweekly servings of
specific foods consumed during pregnancy,
such as smoked meats, cheese, and fish, as
potentially high dietary sources ofPAH. In
addition, subjects were asked about expo-
sure to sources ofPAH either at home or in
the workplace (including coal stoves and
charcoal, tar roofing material, etc.) as well as
exposure to pesticides and other organic
chemicals as potential inducers ofCYPlAI.
All interviews were conducted by two
trained interviewers from the Department
ofEpidemiology and Preventive Medicine,
Jagellonian University (Krakow). Coded
interview data were sent to Columbia
University (New York, NY). Assessment of
smoking status was based on questionnaire
data andplasma cotinine (138).
Daily ambient monitoring data for
Krakow (1990-1992) were provided by the
Division ofNational Sanitary Inspection
(Krakow; 15 monitoring stations) and by
the U.S. Environmental Protection Agency
(5 monitoring stations). Each Krakow
woman's exposure to ambient particulates,
as a proxy for air pollution, was estimated
by taking the average ofPM1o measure-
ments (in micrograms per cubic meter)
reported at the monitoring station closest
to her residence for each of the past 2
years and the month prior to her delivery
date. Ambient particulate data were avail-
able for 69/70 subjects from Krakow. As
there was only one ambient monitoring
station in Limanowa, individual ambient
exposures could not be estimated for
Limanowa subjects.
As a first step in analyzing the effects of
ambient air pollution on biomarker levels
(138), the difference in biomarker levels
between residents of Krakow versus
Limanowa was determined. Then, Krakow
subjects were trichotomized into low-,
medium-, and high-pollution groups based
on the ambient PMIo level at their place of
residence. The difference in biomarker lev-
els across pollution groups was determined
for all Krakow subjects and for Krakow
subjects not employed away from home
during pregnancy. Estimates of exposure
for the latter group were considered more
reliable as unemployed women spend more
oftheir time at their place ofresidence.
For statistical analyses, biomarkers were
log-transformed as needed to stabilize the
variance and obtain a more symmetrical dis-
tribution. Associations were initially evalu-
ated by chi-square and Student's t-test
followed by multivariate analyses. The
regression models included cigarette smoke
exposure, place of residence (Krakow or
Limanowa), ambient pollution group (high,
middle, low; Krakow only), average number
ofservings per week during pregnancy of
foods high in PAH (smoked meat, cheese,
and fish), use ofcoal stoves for residential
heating (yes/no), and home/occupational
exposures to PAH and other organics.
Analysis ofthe relationship between
ambient exposures and adducts. After
controlling for smoking status and other
potential confounders, overall, there was
no difference in the mean PAH-DNA
adduct levels measured by enzyme-linked
immunosorbent assay in mothers and
infants from Krakow compared to those
from Limanowa, possibly because of
higher indoor air concentrations of PAH
from coal burning in Limanowa. Although
coal use (yes/no) was controlled in the
multivariate analyses, more precise mea-
sures ofuse (duration and frequency ofuse
of coal stoves) were not obtained. When
we restricted analysis to the noncoal users,
adduct levels in maternal white blood cells
(WBC) were about 2-fold higher in
Krakow compared to Limanowa (p = 0.03,
Student's t-test).
In Krakow, among subjects for whom
the exposure estimations can be considered
most reliable (those women not employed
away from the home) a dose-response rela-
tionship was seen between PAH-DNA
adduct levels in maternal and infant WBC
(but not placental tissue) and increasing
ambient PM1o pollution at the woman's
residence (p < 0.05, controlling for smok-
ing status and other potential confounders,
Figure 2) (11). The trend for increasing
maternal WBC adduct levels with increas-
ing ambient air pollution groups was statis-
tically significant (p = 0.02). Adduct levels
were significantly increased in women and
newborns residing in the high- compared
to low-pollution area (p < 0.05).
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Figure 2. WBC PAH-DNA adducts by level of air pollution in Krakow subjects not employed outside the home.
Geometric means adjusted by smoking status, dietary PAH, use of coal stoves for residential heating, and
home/occupational exposures to PAH and otherorganics. **p< 0.05 compared to low-pollution group.
Maternal WBC PAH-DNA adduct
levels were significantly associated with
active cigarette smoking status (p < 0.01)
and, among nonsmokers, were signifi-
cantly higher in subjects reporting ETS
exposure compared to those reporting no
ETS exposure (p = 0.01) (11).
There was substantial interindividual
variation (30 to 40-fold) in adduct levels
among the women and infants. These
results are consistent with those from a
Northern Bohemian study in which
PAH-DNA adducts in women's WBC
varied by 26-fold and were highly corre-
lated with individual personal exposures to
PAH monitored over a 24-hr period (139).
The authors noted that the personal expo-
sures were generally relatively low, compa-
rable to those found in other urban areas of
North America and Europe. In spite of
this, there was a sufficiently high interindi-
vidual variability in personal exposures to
PAH to demonstrate a significant correla-
tion between individual PAH exposure and
DNAadducts (r= 0.541,p < 0.016).
Analysis ofthe relationship between
genetic/metabolicfactors, exposure and
biomarkers. A significant association
between ambient pollution at the women's
place ofresidence within Krakow and pla-
cental CYPlAl mRNA was seen among
subjects not employed away from home
(p< 0.05) (138). Placental CYPlAI
mRNA was significantly associated with
active cigarette smoking status and were
highly correlated with infant plasma
cotinine levels (p < 0.001) (11,138). Ex-
smokers also had significantly increased
placental CYPlA1 mRNA levels compared
to nonsmokers. PAH-DNA adduct levels
in both placental tissue and infant WBC
were not significantly associated with
placental CYPlAI MRNA.
GSTM1 is expressed rarely in fetal
tissues, and then only at low levels; there-
fore, infant GSTM1 genotype was not ana-
lyzed. Genotyping at the GSTM1 locus
was completed for 143/160 maternal sam-
ples. Ofthese, 72 (50%) were homozygous
deleted (GSTM1-/-). The remaining 71
(50%) of the women had one or two
copies ofthe gene (GSTM1+/+, +/-).
Determination of the CYPlA1 MspI
RFLP was completed for 142/160 mater-
nal samples. Of these, 24 (17%) were
heterozygous for the restriction site
(CYPlAl MspI+/-) and 118 (83%) did
not have the restriction site (CYPlAI
MspI-/-). None ofthe women were homo-
zygous for the restriction site (CYPlAI
MspI+/+). Determination of the CYPlAl
MspI RFLP was completed on 158/160
infants (140/160 umbilical cord DNA
samples and 149/160 placental DNA
samples). Of these, 29 (18%) were het-
erozygous (CYPlAI MspI-/+) and 3 (2%)
were homozygous (CYPlA1 MspI+/+).
The remaining 126 (80%) of the infants
did not have the restriction site (CYPlAI
MspI-/-). As in other studies, homozy-
gotes and heterozygotes were combined in
the analysis.
Maternal WBC adduct levels were not
associated with either the CYPlAI MspI
RFLP or GSTM1 genotype, before or after
controlling for potential confounders (11),
nor was there an interaction between the
genotypes and exposure on maternal adduct
levels. However, adjusting for potential
confounders, PAH-DNA adduct levels in
both placental tissue and infant WBC were
1.7-fold higher in infants who were
heterozygous or homozygous for the
CYPlAI MspI RFLP than in infants with-
out the restriction site. The difference was
significant for placental tissue (p < 0.01,
n = 158) and ofborderline significance for
infant WBC (p = 0.06, n = 135), control-
ling for potential confounders (11,69).
CYPIAI genotype was not correlated with
CYPlAI enzyme (138). The effect of the
CYPlAl genotype on adduct formation
was greater than that ofCYPlAI activity.
The differing relationship between
CYPlAI and adducts in the women and the
newborns may result in part from reduced
detoxification capabilities via phase II
enzymes in fetal tissues (1,3) rendering the
fetus more susceptible to the effects ofthe
CYPlAI genotype. The results suggest that
a subset ofinfants (those with the CYPIAJ
polymorphism) may be at heightened risk
from environmental exposures to PAH.
Comparison ofthe biomarkers in
mother/infantpairs. Ofthe 160 mothers
and infants in the study, 112 pairs (224
subjects) had adequate amounts of DNA
for adduct analyses. Comparison ofPAH-
DNA adduct levels in these 112 paired
maternal and infant WBC samples showed
that adduct levels were higher in infants
than in mothers (7.9 ± 0.93; vs 5.9 ± 0.77
per 108 nucleotides). Although the dif-
ference was not significant (p = 0.13,
Wilcoxon matched-pairs signed-ranks test),
the results are noteworthy, as the trans-
placental dose of PAH is estimated to be
10-fold lower in the fetus compared to the
mother. Adduct levels in placental tissue
were also significantly higher than those in
paired maternal WBC samples (8.2 ± 0.57
versus 6.4 ± 0.81 per 108 nucleotides,
p < 0.01, Wilcoxon signed-ranks test).
Analysis ofthe association between
PAH-DNA adductlevels andfetaldevel-
opment. Compared to newborns from
Limanowa, Krakow newborns had lower
mean birth weight and significantly lower
birth length and head circumference, before
and after controlling for maternal height,
age, socioeconomic status, history ofLBW,
alcohol consumption, gestational age, gen-
der of the newborn and plasma cotinine
(27). The combination ofknown risk fac-
tors and PAH-DNA adducts did not
explain the observed difference in birth out-
comes between Krakow and Limanowa. It
is possible that unmeasured factors of
urbanization, including constituents of air
pollution other than PAH, are contributing
to fetal growth impairment in Krakow.
Table 1 presents differences in birth
outcomes for newborns with high versus
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Table 1. Difference in birth outcomes for Polish newborns with high (> median) compared to low (<median)
leukocyte PAH-DNA adduct levels.a
Birth weight Birth length Head circumference
Difference (g) p-Value Difference(cm) p-Value Difference (cm) p-value
Krakow newborns (n= 58) -205 0.11 -1.8 0.02 -0.9 0.05
Limanowa newborns (n=77) -129 0.16 -0.8 0.17 -1.2 0.0004
All newborns (Krakow+ limanowa) -147 0.05 -1.1 0.02 -0.9 0.0005
'Controlling formatemal height, age, socioeconomic status (education level), history of lowbirth weight, maternal alcohol consump-
tion, gestational age(weeks), genderofthe newborn, and plasma cotinine(ng/mL). Median adduct level 3.85/108 nucleotides.
low PAH-DNA adducts (27). In both
Krakow and Limanowa groups analyzed
separately, all three measures (birth weight,
length, and head circumference) were
decreased in newborns with high adduct
levels, although the differences were not
significant in all cases. Among Krakow
newborns, those with elevated PAH-DNA
adducts had significantly decreased birth
length (by 1.8 cm, p = 0.02) and head cir-
cumference (by 0.9 cm, p = 0.05). Among
Limanowa newborns, those with elevated
adducts had significantly decreased head
circumference (by 1.2 cm, p = 0.0004).
Considering all the newborns combined
(Krakow and Limanowa), those with high
PAH-DNA adducts had significantly
lower birth weight (p = 0.05), birth length
(p= 0.02), and head circumference
(p = 0.0005) than newborns with low
adducts (27).
After combining the two groups and
removing current smokers in order to inves-
tigate the effects ofPAH in the absence of
active smoking by the mother, all three mea-
sures offetal development remained signifi-
cantly lower among those with high versus
lowadducts (p < 0.03). To remove the effect
ofboth active and passive smoking, analyses
were further restricted to the 53 newborns of
nonsmokers without detectable plasma coti-
nine. The newborns with elevated adducts
had decreased birth weight (by 217 g,
p = 0.1) and length (by 0.8 cm, p > 0.2) and
significantly decreased head circumference
(by 1.3 cm, p = 0.006). When PAH-DNA
adducts among all the newborns were
included in the regression models as a con-
tinuous variable, they were inversely,
although not significantly, correlated with
birth weight and length. Adducts were
inversely correlated with head circumference
both before (p = 0.006) and aftercontrolling
for birth weight (p = 0.003), suggesting
asymmetrical growth retardation (27).
The results do not imply that develop-
mental damage is necessarily mediated by
DNAbinding, although that is one possible
mechanism. Here the extent ofDNA bind-
ing by PAH in newborn leukocytes has
been used as a dosimeter ofPAH that have
reached the fetus. Neither the mechanisms
bywhich PAH exert developmental toxicity
nor the target sites have been identified
(27). Indeed, it is possible that PAH act by
more than one mechanism. For example, it
has been hypothesized that B[a]P exposure
may interfere with uterine growth during
pregnancy due to its antiestrogenic effects,
thereby disrupting the endocrine system
(29). Similar to PCBs, which are associated
with deficits in fetal growth and IQ
(140,141), PAH bind to the human Ah
receptor to induce P450 enzymes (142).
Additionally, the developing CNS appears
particularly sensitive to DNA-damaging
agents (91) and may respond by activating
apoptotic pathways (92). For example, in
humans, fetal microcephaly has been seen
following exposure to ionizing radiation
(143) and anticonvulsant drugs (144). Risk
from anticonvulsants was most pronounced
in infants deficient in enzymes that detoxify
the DNA-binding intermediate (145,146).
It is of interest that, in this Polish cohort,
PAH-DNA adduct levels were most
strongly associated with reduction in head
circumference, and the data were suggestive
ofasymmetrical growth retardation related
to DNAbinding.
Analys oftheRelationship
between Cotinineand
Biomarkers/Development
Maternal and infant cotinine levels were
increased significantly by active cigarette
smoking ofthe mother (p < 0.0001) (83).
Additionally, for women who reported not
smoking during pregnancy, cotinine levels
in both mothers and infants were sig-
nificantly increased with ETS exposure
(p < 0.01). An inverse correlation was seen
between newborn plasma cotinine (nano-
grams per milliliter) and birth weight
(p = 0.0001) and birth length (p = 0.003),
controlling for place ofresidence and other
potential confounders. The effect of coti-
nine on outcomes was independent ofthat
ofPAH-DNA adducts (27). Further, coti-
nine provided a better fit (i.e., explained
more ofthe variance in birth weight) than
other measures ofmaternal smoking derived
from the questionnaire, none ofwhich were
significantly associated with birth weight
(83). Cotinine levels in infant samples were
higher than in paired maternal samples, a
difference that was significant both for the
total cohort (14.2 ± 2.8 vs 8.3 ± 2.0,
p < 0.0001) and after analyses were
restricted to mother/infant pairs for whom
blood samples were collected within 6 hr of
one another (average of0.9 ± 1.2 hr SD;
10.6 ± 3.5 vs 8.0 ± 2.6,p = 0.0001).
Summary
In conclusion, these results indicate that
there is significant transplacental transfer
of PAH and ETS constituents from
mother to fetus; that maternal and infant
WBC PAH-DNA adduct levels were
increased with environmental exposure to
PAH from ambient pollution; and that
plasma cotinine is increased by ETS. The
finding of higher adduct levels in the
infant compared to the mother suggests
increased susceptibility of the developing
fetus to DNA damage, whereas the finding
ofhigher cotinine levels suggests reduced
capability ofthe developing fetus to detox-
ify and clear cigarette smoke constituents.
The study also provided the first molecular
evidence that transplacental PAH exposure
to the fetus may be compromising fetal
development. Although these findings
implicate DNA damage as the mechanism,
it should be noted that, like PCB, PAH
are capable ofinducing P450s and disrupt-
ing the endocrine system. A follow-up
study is needed to confirm whether
IQ/cognitive function is decreased among
children with smaller head circumference
associated with exposure. If confirmed,
these findings could have significant public
health implications, as a number ofstudies
have found that reduction of head cir-
cumference at birth correlates with lower
IQ as well as poorer cognitive functioning
and school performance in childhood
(20,25,26).
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